Raymond James Financial Inc Precigen, Inc. Transaction History
Raymond James Financial Inc
- $299 Billion
- Q3 2025
A detailed history of Raymond James Financial Inc transactions in Precigen, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 28,169 shares of PGEN stock, worth $129,859. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,169
Previous 17,649
59.61%
Holding current value
$129,859
Previous $25,000
268.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PGEN
# of Institutions
188Shares Held
194MCall Options Held
6.61MPut Options Held
2.06M-
Third Security, LLC83.5MShares$385 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD26.5MShares$122 Million4.02% of portfolio
-
Tang Capital Management LLC San Diego, CA12.4MShares$57.2 Million1.85% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$47.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.94MShares$41.2 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $960M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...